Currency Grow (CA & SEBI Reg IA Omkar Bhutada) · 12th Jun
Solara Active Pharma: Multi-Signal Breakout on a Fundamentally Strong Stock
SOLARA
Solara Active Pharma appears to be completing a large Cup & Handle formation, with price now decisively moving above the key resistance zone around ₹580-585. The structure suggests the stock may be entering the final phase of a larger bullish Elliott Wave sequence. The rounded base from March to May can be interpreted as Wave 2 correction, while the current breakout may mark the beginning of an impulsive Wave 3, typically the strongest wave in the cycle.
From a momentum perspective, MACD has turned bullish again after a healthy pullback, indicating renewed buying strength. Despite the recent consolidation, MACD maintained a higher low compared to previous swings, reflecting underlying bullish momentum and reducing the probability of a deeper correction.
The stock is also trading comfortably above its major moving averages, and the AVWAP from the recent swing low aligns near the ₹535-545 zone, making it an important institutional support area. As long as price sustains above this region, the broader uptrend remains intact. The breakout above ₹580 has converted previous resistance into support, improving the risk-reward setup.
Fundamentally, Solara continues to attract attention due to its improving business performance, healthy operating metrics, and the potential for earnings expansion. Companies demonstrating strong capital efficiency, improving profitability, and consistent growth often witness sustained institutional participation, which can support longer-term price appreciation.
Technical Outlook
Pattern: Cup & Handle Breakout
Breakout Zone: ₹580-585
Immediate Support: ₹580
AVWAP Support Area: ₹535-545
Bullish Confirmation: MACD positive crossover
Potential Targets: ₹650 → ₹700+
Invalidation: Sustained close below ₹535
The combination of Elliott Wave progression, bullish MACD structure, AVWAP support alignment, and improving fundamentals creates a strong multi-factor setup worth tracking in the coming weeks.